[
  {
    "ts": null,
    "headline": "Compared to Estimates, DexCom (DXCM) Q1 Earnings: A Look at Key Metrics",
    "summary": "Although the revenue and EPS for DexCom (DXCM) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
    "url": "https://finnhub.io/api/news?id=4b31ac8ad434401ef9f44d820645d21b4ad70f4325626cf4dc8b48b25c040583",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746135006,
      "headline": "Compared to Estimates, DexCom (DXCM) Q1 Earnings: A Look at Key Metrics",
      "id": 134185435,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "Although the revenue and EPS for DexCom (DXCM) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
      "url": "https://finnhub.io/api/news?id=4b31ac8ad434401ef9f44d820645d21b4ad70f4325626cf4dc8b48b25c040583"
    }
  },
  {
    "ts": null,
    "headline": "DexCom (NASDAQ:DXCM) Exceeds Q1 Expectations",
    "summary": "Medical device company DexCom (NASDAQ:DXCM) announced better-than-expected revenue in Q1 CY2025, with sales up 12.5% year on year to $1.04 billion. The company expects the full year’s revenue to be around $4.6 billion, close to analysts’ estimates. Its non-GAAP profit of $0.32 per share was in line with analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=8472dd841c3e833c3f667693861b6b89a0bf9cd94da2ae261a0b8cca98638891",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746134714,
      "headline": "DexCom (NASDAQ:DXCM) Exceeds Q1 Expectations",
      "id": 134185436,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "Medical device company DexCom (NASDAQ:DXCM) announced better-than-expected revenue in Q1 CY2025, with sales up 12.5% year on year to $1.04 billion. The company expects the full year’s revenue to be around $4.6 billion, close to analysts’ estimates. Its non-GAAP profit of $0.32 per share was in line with analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=8472dd841c3e833c3f667693861b6b89a0bf9cd94da2ae261a0b8cca98638891"
    }
  },
  {
    "ts": null,
    "headline": "DexCom (DXCM) Q1 Earnings Miss Estimates",
    "summary": "DexCom (DXCM) delivered earnings and revenue surprises of -3.03% and 1.99%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=981536cb33cbcf7bd5b0447a18c432b293b442bbf52eb689882ac8195fcffbfe",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746134108,
      "headline": "DexCom (DXCM) Q1 Earnings Miss Estimates",
      "id": 134185438,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "DexCom (DXCM) delivered earnings and revenue surprises of -3.03% and 1.99%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=981536cb33cbcf7bd5b0447a18c432b293b442bbf52eb689882ac8195fcffbfe"
    }
  },
  {
    "ts": null,
    "headline": "DexCom, Inc. (DXCM) Q1 2025 Earnings Call Transcript",
    "summary": "DexCom, Inc. (NASDAQ:DXCM) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ETCompany ParticipantsSean Christensen - VP, Finance &amp; IRKevin Sayer -...",
    "url": "https://finnhub.io/api/news?id=494a0eae37371852dcb4a3e961023a6b75511b324cb0066887505c1f68132931",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746133443,
      "headline": "DexCom, Inc. (DXCM) Q1 2025 Earnings Call Transcript",
      "id": 134178630,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "DXCM",
      "source": "SeekingAlpha",
      "summary": "DexCom, Inc. (NASDAQ:DXCM) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ETCompany ParticipantsSean Christensen - VP, Finance &amp; IRKevin Sayer -...",
      "url": "https://finnhub.io/api/news?id=494a0eae37371852dcb4a3e961023a6b75511b324cb0066887505c1f68132931"
    }
  },
  {
    "ts": null,
    "headline": "DexCom: Q1 Earnings Snapshot",
    "summary": "On a per-share basis, the San Diego-based company said it had net income of 27 cents. Earnings, adjusted for pretax expenses and amortization costs, came to 32 cents per share. The results did not meet Wall Street expectations.",
    "url": "https://finnhub.io/api/news?id=fe4d21b16203d0429ad411d61fad8ac4b9414ad19a31eaeef1da16fef3be2746",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746130452,
      "headline": "DexCom: Q1 Earnings Snapshot",
      "id": 134185439,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "On a per-share basis, the San Diego-based company said it had net income of 27 cents. Earnings, adjusted for pretax expenses and amortization costs, came to 32 cents per share. The results did not meet Wall Street expectations.",
      "url": "https://finnhub.io/api/news?id=fe4d21b16203d0429ad411d61fad8ac4b9414ad19a31eaeef1da16fef3be2746"
    }
  },
  {
    "ts": null,
    "headline": "Dexcom Reports First Quarter 2025 Financial Results and Announces $750 Million Share Repurchase Program",
    "summary": "SAN DIEGO, May 01, 2025--Dexcom Reports First Quarter 2025 Financial Results and Announces $750 Million Share Repurchase Program",
    "url": "https://finnhub.io/api/news?id=5c933c6a68ed55928f7d3c372da0e3ea9c803f6105e77ff93860348a52b7d83d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746129720,
      "headline": "Dexcom Reports First Quarter 2025 Financial Results and Announces $750 Million Share Repurchase Program",
      "id": 134185440,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "SAN DIEGO, May 01, 2025--Dexcom Reports First Quarter 2025 Financial Results and Announces $750 Million Share Repurchase Program",
      "url": "https://finnhub.io/api/news?id=5c933c6a68ed55928f7d3c372da0e3ea9c803f6105e77ff93860348a52b7d83d"
    }
  },
  {
    "ts": null,
    "headline": "DexCom Inc. stock underperforms Thursday when compared to competitors",
    "summary": "DexCom Inc. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=e26425ba288b82450a2002d236d4a112e9fc7473477876e354323237c8aefd80",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746118740,
      "headline": "DexCom Inc. stock underperforms Thursday when compared to competitors",
      "id": 134280627,
      "image": "",
      "related": "DXCM",
      "source": "MarketWatch",
      "summary": "DexCom Inc. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=e26425ba288b82450a2002d236d4a112e9fc7473477876e354323237c8aefd80"
    }
  },
  {
    "ts": null,
    "headline": "Dexcom beats quarterly sales estimates, reiterates annual forecast",
    "summary": "Medical device maker Dexcombeat first-quarter sales estimates helped by strong demand forits continuous glucose monitors used by patients withdiabetes. Shares of the company rose...",
    "url": "https://finnhub.io/api/news?id=03cd7dca28e1433352b296f667fafc8ab80719e553be50616350f9c8b14c1bbc",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746118207,
      "headline": "Dexcom beats quarterly sales estimates, reiterates annual forecast",
      "id": 134177427,
      "image": "",
      "related": "DXCM",
      "source": "Finnhub",
      "summary": "Medical device maker Dexcombeat first-quarter sales estimates helped by strong demand forits continuous glucose monitors used by patients withdiabetes. Shares of the company rose...",
      "url": "https://finnhub.io/api/news?id=03cd7dca28e1433352b296f667fafc8ab80719e553be50616350f9c8b14c1bbc"
    }
  },
  {
    "ts": null,
    "headline": "Transcript : DexCom, Inc., Q1 2025 Earnings Call, May 01, 2025",
    "summary": "Presentation Operator MessageOperator Welcome to the DexCom First Quarter 2025 Earnings Release Conference Call. My name is Louella, and I will be your operator for today's call. [Operator...",
    "url": "https://finnhub.io/api/news?id=fb5a9e2ef99c54e66ce8c812b501628fe8fba379d916fe621278cdd2c88a2bf5",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746088200,
      "headline": "Transcript : DexCom, Inc., Q1 2025 Earnings Call, May 01, 2025",
      "id": 135310482,
      "image": "",
      "related": "DXCM",
      "source": "Finnhub",
      "summary": "Presentation Operator MessageOperator Welcome to the DexCom First Quarter 2025 Earnings Release Conference Call. My name is Louella, and I will be your operator for today's call. [Operator...",
      "url": "https://finnhub.io/api/news?id=fb5a9e2ef99c54e66ce8c812b501628fe8fba379d916fe621278cdd2c88a2bf5"
    }
  }
]